Related Experiment Video
Updated: May 26, 2026

An In Vitro Protocol for Evaluating MicroRNA Levels, Functions, and Associated Target Genes in Tumor Cells
Published on: May 21, 2019
MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer
Yushi Ikeda1, Etsuko Tanji, Naohiko Makino
1International Research and Educational Institute for Integrated Medical Sciences, Tokyo Women's Medical University, Tokyo, Japan.
Abstract:
Aberrant expression of microRNAs (miRNA) is associated with phenotypes of various cancers, including pancreatic cancer. However, the mechanism of the aberrant expression is largely unknown. Activation of the mitogen-activated protein kinase (MAPK) signaling pathway plays a crucial role in gene expression related to the malignant phenotype of pancreatic cancer. Hence, we studied the role of MAPK in the aberrant expression of miRNAs in pancreatic cancer cells. The alterations in expression of 183 miRNAs induced by activation or inactivation of MAPK were assayed in cultured pancreatic cancer cells and HEK293 cells by means of the quantitative real-time PCR method. We found that four miRNAs, namely, miR-7-3, miR-34a, miR-181d, and miR-193b, were preferentially associated with MAPK activity. Among these miRNAs, miR-7-3 was upregulated by active MAPK, whereas the others were downregulated. Promoter assays indicated that the promoter activities of the host genes of miR-7-3 and miR-34a were both downregulated by alteration in MAPK activity. Exogenous overexpression of the MAPK-associated miRNAs had the effect of inhibition of the proliferation of cultured pancreatic cancer cells; miR-193b was found to exhibit the most remarkable inhibition. A search for target genes of miR-193b led to identification of CCND1, NT5E, PLAU, STARD7, STMN1, and YWHAZ as the targets. Translational suppression of these genes by miR-193b was confirmed by reporter assay. These results indicate that activation of MAPK may play a significant role in aberrant expression of miRNAs and their associated phenotypes in pancreatic cancer.
Insights
Mitogen-activated protein kinase (MAPK) pathway activation influences microRNA (miRNA) expression in pancreatic cancer. This study identified specific miRNAs regulated by MAPK, with miR-193b showing significant potential to inhibit cancer cell proliferation.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Aberrant microRNA (miRNA) expression is linked to pancreatic cancer phenotypes.
- The mechanisms driving miRNA dysregulation in pancreatic cancer remain largely unknown.
- The mitogen-activated protein kinase (MAPK) signaling pathway is implicated in pancreatic cancer progression.
Purpose of the Study:
- To investigate the role of MAPK signaling in the aberrant expression of miRNAs in pancreatic cancer cells.
- To identify specific miRNAs regulated by MAPK activity.
- To assess the impact of MAPK-associated miRNAs on pancreatic cancer cell proliferation.
Main Methods:
- Quantitative real-time PCR was used to assay expression changes of 183 miRNAs.
- MAPK activation and inactivation were induced in cultured pancreatic cancer cells and HEK293 cells.
- Promoter assays and reporter assays were employed to validate gene regulation and target suppression.
Main Results:
- Four miRNAs (miR-7-3, miR-34a, miR-181d, miR-193b) were significantly associated with MAPK activity.
- miR-7-3 was upregulated by active MAPK; miR-34a, miR-181d, and miR-193b were downregulated.
- Overexpression of these miRNAs inhibited pancreatic cancer cell proliferation, with miR-193b showing the strongest effect.
- CCND1, NT5E, PLAU, STARD7, STMN1, and YWHAZ were identified as miR-193b targets.
Conclusions:
- MAPK signaling plays a significant role in the aberrant expression of miRNAs in pancreatic cancer.
- MAPK-regulated miRNAs contribute to pancreatic cancer phenotypes.
- miR-193b demonstrates potential as a therapeutic agent by inhibiting cancer cell proliferation and targeting key genes.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
MicroRNAs
MicroRNAs

